IL1B and diabetes mellitus: Remarkably, some authors have reported that treatment with soluble IL-1 receptor or neutralizing anti-IL-1β pAb prevents cyclophosphamide-induced diabetes in NOD mice (Nicoletti et al, 1994; Cailleau et al, 1997).